Prophylaxis of Post-Inflammatory Hyperpigmentation from Energy-Based Device Treatments |
Molecule Updates
eMediNexus Coverage from: 
Prophylaxis of Post-Inflammatory Hyperpigmentation from Energy-Based Device Treatments
eMediNexus,  20 February 2021
Coronavirus Live Count Map India

remove_red_eye 489 Views
COVID-19 Vaccine Updates

#Dermatology

1 Read Comments                

A new article published in the Journal of Cutaneous Medicine and Surgery discussed that post-inflammatory hyperpigmentation (PIH) is an acquired hypermelanosis that can result from inflammatory dermatologic disease, trauma or may be iatrogenic. This condition disproportionately affects individuals with colored skin, and it can place a significant psychosocial burden on affected patients. 

This review observed that prophylaxis strategies to prevent PIH vary greatly in clinical practice, likely due to the absence of an evidence-based consensus. Published approaches to PIH prophylaxis include pretreatment and post-treatment strategies. Pretreatment modalities comprise – topical alpha hydroxy acids, retinoids, hydroquinone and brimonidine, whereas post-treatment modalities are – photo protection, corticosteroids and tranexamic acid. 

Source: Journal of Cutaneous Medicine and Surgery. Jan-Feb 2021;25(1):77-86. doi: 10.1177/1203475420957633.
To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now